NCT04674904

Effects of Dry Needling in Patients With Upper Cross Syndrome

Completed NA Last updated 8 March 2021

What this trial tests

NA trial testing Dry Needling in Neck Syndrome in 34 participants. Completed in 30 January 2021.

Timeline

30 March 2020

Primary endpoint
30 December 2020

30 January 2021

Quick facts

Lead sponsor	Riphah International University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	34
Start date	30 March 2020
Primary completion	30 December 2020
Estimated completion	30 January 2021
Sites	1 location across Pakistan

Drugs / interventions tested

• Dry Needling
• Hot pack , TENS , Stretching

Conditions studied

• Neck Syndrome — all drugs for Neck Syndrome →

Sponsor

Riphah International University

Who can join

Adults 20 to 50, any sex, with Neck Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study will be done to evaluate the effectiveness of dry needling of muscles involved in Upper Cross Syndrome. Muscles involved in upper cross syndrome are tight upper trap, Levator Scapulae, Sternocledomastoid , Pectorals major and minor and rhomboids. Physical assessment of trigger points will locate the target area for dry needling. After pre treatment measurements, dry needling will be performed to treatment group and stretching, hot pack and tens will be apply in control group. Study design will be randomized controlled trial and sample size will be 34 participants. Data will be collected from Riphah Rehabilitation Center. Patients of 20-50 years old with UCS diagnosed through observation and physical examination will be included. Patients with systemic soft tissue and bony diseases will be excluded. Intervention duration will be two session of DNT with two weeks routine management. Basic tools will be Visual analog scale (VAS), Neck Disability Index (NDI) and Goniometry

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.